Targeting AEBP1 to mitigate pro-tumor activity of cancer-associated fibroblasts and increase therapeutic efficacy to anti-PD-1
RNA-seq (gene expression) · mouse · 12 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 12 samples: 3 × NIH3T3_WT_Par_passage vs 3 × NIH3T3_KO_F5_passage vs 3 × NIH3T3_KO_G5_passage vs 3 × NIH3T3_KO_H7_passageGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE301078_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1283225 and SRA study SRP595682. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
How we read this: 4 replicated groups read from 12 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9074761 NIH3T3_WT_Par_passage6 NIH3T3_WT_Par_passage
- GSM9074762 NIH3T3_WT_Par_passage7 NIH3T3_WT_Par_passage
- GSM9074763 NIH3T3_WT_Par_passage8 NIH3T3_WT_Par_passage
- GSM9074764 NIH3T3_KO_F5_passage7 NIH3T3_KO_F5_passage
- GSM9074765 NIH3T3_KO_F5_passage8 NIH3T3_KO_F5_passage
- GSM9074766 NIH3T3_KO_F5_passage9 NIH3T3_KO_F5_passage
- GSM9074767 NIH3T3_KO_G5_passage7 NIH3T3_KO_G5_passage
- GSM9074768 NIH3T3_KO_G5_passage8 NIH3T3_KO_G5_passage
- GSM9074769 NIH3T3_KO_G5_passage9 NIH3T3_KO_G5_passage
- GSM9074770 NIH3T3_KO_H7_passage7 NIH3T3_KO_H7_passage
- GSM9074771 NIH3T3_KO_H7_passage8 NIH3T3_KO_H7_passage
- GSM9074772 NIH3T3_KO_H7_passage9 NIH3T3_KO_H7_passage
- GSE308848 Targeting AEBP1 to mitigate pro-tumor activity of cancer-associated fibroblasts and increase therapeutic efficacy to anti-PD-1 [scRNA-Seq] 12 samples shares anti-pd-1, aebp1, cancer-associated, fibroblasts, therapeutic, targeting, pro-tumor, mitigate
- GSE300401 Targeting cancer-associated fibroblast-mediated LIF/LIFR axis improves the therapeutic efficacy of gemcitabine and nab-paclitaxel in pancreatic cancer 12 samples shares cancer-associated, therapeutic, targeting
- GSE306627 TGFβ signaling in cancer-associated fibroblasts drives a hepatic gp130-dependent pro-metastatic inflammatory program in colorectal cancer 42 samples shares cancer-associated, fibroblasts
- GSE254072 A unique genetic signature for cancer-associated fibroblasts in Melanoma metastases 21 samples shares cancer-associated, fibroblasts
- GSE296064 Gene expression analysis of normal mammary gland fibroblasts (NFs) and cancer-associated fibroblasts (CAFs) from the murine breast cancer model MMTV-PyMT after perturbing the expression of Hsp90aa1 and Hsp90ab1 by RNAi 21 samples shares cancer-associated, fibroblasts
- GSE235242 Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma suppress CD8+ T cell activation and inhibit response to immune checkpoint therapy [Kras_p53] 14 samples shares cancer-associated, fibroblasts
- GSE271805 Lymphoma B cells remodel bone marrow stromal cell network into extracellular matrix-producing cancer-associated fibroblasts (scRNAseq) 4 samples shares cancer-associated, fibroblasts
- GSE334585 iNOS is a key mediator of anti-PD-1 melanoma therapy response 48 samples shares anti-pd-1
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.